ICATIBANT Drug Patent Profile
✉ Email this page to a colleague
When do Icatibant patents expire, and what generic alternatives are available?
Icatibant is a drug marketed by Alembic, Caplin, Cipla, Eugia Pharma, Fresenius Kabi Usa, Glenmark Pharms Ltd, Jiangsu Hansoh Pharm, Nang Kuang Pharm Co, Teva Pharms Usa, and Wilshire Pharms Inc. and is included in ten NDAs.
The generic ingredient in ICATIBANT is icatibant acetate. There are thirteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the icatibant acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Icatibant
A generic version of ICATIBANT was approved as icatibant acetate by TEVA PHARMS USA on July 15th, 2019.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ICATIBANT?
- What are the global sales for ICATIBANT?
- What is Average Wholesale Price for ICATIBANT?
Summary for ICATIBANT
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 10 |
| Drug Prices: | Drug price information for ICATIBANT |
| What excipients (inactive ingredients) are in ICATIBANT? | ICATIBANT excipients list |
| DailyMed Link: | ICATIBANT at DailyMed |
US Patents and Regulatory Information for ICATIBANT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alembic | ICATIBANT ACETATE | icatibant acetate | INJECTABLE;SUBCUTANEOUS | 213773-001 | Jun 14, 2024 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Jiangsu Hansoh Pharm | ICATIBANT ACETATE | icatibant acetate | INJECTABLE;SUBCUTANEOUS | 211021-001 | Mar 9, 2020 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Eugia Pharma | ICATIBANT ACETATE | icatibant acetate | INJECTABLE;SUBCUTANEOUS | 213521-001 | Aug 14, 2023 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Nang Kuang Pharm Co | ICATIBANT ACETATE | icatibant acetate | INJECTABLE;SUBCUTANEOUS | 212081-001 | Dec 16, 2020 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
